돌아가기
Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
HRID 249234생성일: 2026년 10월 25일

Cholesterol → Epirubicin Hydrochloride

https://huagongshe.com/reaction/249234

반응식

참여 물질

역할이름HCID투입량
반응물CholesterolHCID 5997—
반응물ChloroformHCID 6212—
반응물EpirubicinHCID 41867—
반응물[3-[hydroxy-[2-[[4-(2-methoxyethoxy)-4-oxobutanoyl]amino]ethoxy]phosphoryl]oxy-2-[(E)-octadec-9-enoyl]oxypropyl] (E)-octadec-9-enoateHCID 6440842—
생성물Epirubicin HydrochlorideHCID 65348—
생성물Doxorubicin HydrochlorideHCID 443939—

반응 단계

Vesicle-forming lipids containing PEG-PE, PG, PHEPC, and cholesterol and α-TC in a mole ratio of 0.15: 0.3: 1.85: 1: 0.2 were dissolved in chloroform to a final lipid concentration of 25 μmol phospholipid/ml. The lipid mixture was dried into a thin film under reduced pressure. The film was hydrated with a solution of 0.125 M ammonium sulfate to form MLVs. The MLV suspension was frozen in a dry ice acetone bath and thawed three times and sized to 80-100 nm by extrusion as detailed above. An ammonium ion gradient was created substantially as described in Example 10. The liposomes were loaded with epirubicin, and free (unbound drug) removed also as described in Example 10 for doxorubicin. The final concentration of entrapped drug was about 50-100 μg drug/μmol lipid. Epirubicin HCl and doxorubicin HCL, the commercial products, were obtained from the hospital pharmacy.

출처 및 근거

DOI10.6084/m9.figshare.5104873.v1
특허 번호US05213804
출처 데이터셋uspto-grants-1993_05
ORD IDord-a8c09ad378a649a4bf286246ad752077
출처 메모uspto-grants-1993_05